Takeda Pharmaceutical Company Limited announced that its Board of Directors decided to promote Christophe Weber, Representative Director, President & Chief Operating Officer (COO), to Representative Director, President & Chief Executive Officer (CEO), effective April 1, 2015. Yasuchika Hasegawa, Representative Director, Chairman of the Board & CEO, will assume the position of Representative Director, Chairman of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4,130 JPY | -0.19% | +1.47% | +1.87% |
May. 16 | Takeda Canada Completes LOI Stage for Post-Transplant Cytomegalovirus Treatment | MT |
May. 15 | Takeda Pharmaceutical's Dengue Vaccine Granted WHO Prequalification | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.87% | 41.81B | |
+32.31% | 694B | |
+29.39% | 593B | |
-1.54% | 371B | |
+20.10% | 331B | |
+7.19% | 290B | |
+14.25% | 239B | |
-3.03% | 209B | |
+10.02% | 209B | |
+8.51% | 169B |
- Stock Market
- Equities
- 4502 Stock
- News Takeda Pharmaceutical Company Limited
- Takeda Pharmaceutical Company Limited Announces Executive Changes